| 1. | | Recruiting | TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma (TCC) of the Urothelium
Conditions: Bladder Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Carcinoma, Transitional Cell |
| 2. | | Recruiting | Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Conditions: transitional cell carcinoma of the bladder; recurrent bladder cancer; stage III bladder cancer; stage IV bladder cancer |
| 3. | | Recruiting | Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Conditions: transitional cell carcinoma of the bladder; stage 0 bladder cancer; stage I bladder cancer |
| 4. | | Recruiting | Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Conditions: stage 0 bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; ... |
| 5. | | Recruiting | Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder
Conditions: transitional cell carcinoma of the bladder; stage I bladder cancer |
| 6. | | Recruiting | Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
Conditions: recurrent bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ... |
| 7. | | Recruiting | Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder |
| 8. | | Recruiting | Tipifarnib in Treating Patients With Recurrent Bladder Cancer
Conditions: recurrent bladder cancer; stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder |
| 9. | | Recruiting | Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer
Conditions: stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; transitional cell carcinoma of the bladder |
| 10. | | Recruiting | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder |
| 11. | | Recruiting | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
Conditions: stage II bladder cancer; stage III bladder cancer; transitional cell carcinoma of the bladder; squamous cell carcinoma of the bladder; ... |
| 12. | | Recruiting | BCG With or Without Mitomycin in Treating Patients With Bladder Cancer
Conditions: stage 0 bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder |
| 13. | | Recruiting | Combination Chemotherapy in Treating Patients With Bladder Cancer
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder |
| 14. | | Recruiting | Combination Chemotherapy in Treating Patients With Bladder Cancer
Conditions: stage I bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder |
| 15. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ... |
| 16. | | Recruiting | Surgery and BCG in Treating Patients With Bladder Cancer
Conditions: stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder |
| 17. | | Recruiting | FR901228 in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 18. | | Recruiting | Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 19. | | Recruiting | Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 20. | | Recruiting | Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 21. | | Recruiting | Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 22. | | Recruiting | Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 23. | | Recruiting | Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 24. | | Recruiting | Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 25. | | Recruiting | Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 26. | | Recruiting | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 27. | | Recruiting | Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 28. | | Recruiting | Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
Conditions: stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; anterior urethral cancer; posterior urethral cancer; ... |
| 29. | | Recruiting | Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy
Condition: Bladder Cancer |
| 30. | | Recruiting | Safety and Efficacy of S-8184 in Second Line Treatment of Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium
Condition: Urologic Neoplasms |
